Guggenheim analyst Subbu Nambi noted that Advocate General Nicolas Emiliou issued an opinion to side with Illumina as part of Illumina’s jurisdictional appeal in the EU, urging the European Court of Justice to set aside the judgement on GRAIL. While AG opinion is non-binding, ECJ judges follow the AG opinion in the majority of cases and this could mean that Illumina will no longer be required to fund GRAIL for 2.5 years upon divestiture, the analyst tells investors. Guggenheim, which notes that the firm’s and the Street’s worst case scenario was almost $2.5B, keeps a Buy rating on Illumina shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ILMN:
- Early notable gainers among liquid option names on March 19th
- China stimulus positive for GE HealthCare, tool companies, says Evercore ISI
- Icahn drops threat to challenge Illumina board, Reuters reports
- Early notable gainers among liquid option names on February 26th
- Illumina participates in a conference call with TD Cowen